Literature DB >> 407593

Brain monoamine oxidase activity after chronic ethanol treatment of rats.

A Wiberg, G Wahlstroöm, L Oreland.   

Abstract

Rats were given chronic treatments with ethanol in two ways: by offering 10% ethanol in water as the only liquid supply for 34 weeks and by exposing the rats to ethanol vapour during 5 h daily for 7 weeks. In this way blood ethanol levels of 1.4-2.3 and 5.5-6.9 mg/ml, respectively, were accomplished. In neither of the cases was brain monoamine oxidase activity changed. The result supports an hypothesis previously advanced that the lowered monoamine oxidase activity found in the brain of a suicide patient was not due to a direct effect of ethanol on alcoholics in the suicide group, but that the low enzyme activity reflected a low monoaminergic activity in the brains of the patients in the suicide group.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407593     DOI: 10.1007/bf00439095

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

Review 1.  Involvement of biogenic amine metabolism in ethanol addiction.

Authors:  R A Deitrich; V G Erwin
Journal:  Fed Proc       Date:  1975-09

2.  AN AMINE OXIDASE IN NORMAL HUMAN SERUM.

Authors:  C M MCEWEN; J D COHEN
Journal:  J Lab Clin Med       Date:  1963-11

3.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE.

Authors:  R J WURTMAN; J AXELROD
Journal:  Biochem Pharmacol       Date:  1963-12       Impact factor: 5.858

4.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

Authors:  E G GRAY; V P WHITTAKER
Journal:  J Anat       Date:  1962-01       Impact factor: 2.610

Review 5.  Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.

Authors:  N H Neff; H Y Yang
Journal:  Life Sci       Date:  1974-06-01       Impact factor: 5.037

6.  Interaction and acute cross tolerance between ethanol and hexobarbitone in the rat.

Authors:  G Wahlström; E Widerlöv
Journal:  J Pharm Pharmacol       Date:  1971-01       Impact factor: 3.765

7.  5-Hydroxytryptamine and 5-hydroxyindolylacetic acid content in brain of rat strains selected for their alcohol intake.

Authors:  L Ahtee; K Eriksson
Journal:  Physiol Behav       Date:  1972-01

8.  Soluble and membrane-bound pig liver mitochondrial monoamine oxidase: thermostability, tryptic digestability and kinetic properties.

Authors:  L Oreland; B Ekstedt
Journal:  Biochem Pharmacol       Date:  1972-09-15       Impact factor: 5.858

9.  Determination of ethanol in blood by gas chromatography.

Authors:  A S Curry; G W Walker; G S Simpson
Journal:  Analyst       Date:  1966-11       Impact factor: 4.616

10.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

Authors:  M Asberg; L Träskman; P Thorén
Journal:  Arch Gen Psychiatry       Date:  1976-10
View more
  5 in total

1.  Platelet monoamine oxidase activity predicts alcohol sensitivity and voluntary alcohol intake in rhesus monkeys.

Authors:  Hanna-Linn Wargelius; Claudia Fahlke; Stephen J Suomi; Lars Oreland; James Dee Higley
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

2.  The activity of monoamine oxidase -A and -B in brains from chronic alcoholics.

Authors:  L Oreland; A Wiberg; B Winblad; C J Fowler; C G Gottfries; K Kiianmaa
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

3.  Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.

Authors:  C M Banki
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 4.  Genetics and biological markers of risk for alcoholism.

Authors:  B Tabakoff; P L Hoffman
Journal:  Public Health Rep       Date:  1988 Nov-Dec       Impact factor: 2.792

5.  Effect of voluntary alcohol consumption on Maoa expression in the mesocorticolimbic brain of adult male rats previously exposed to prolonged maternal separation.

Authors:  M Bendre; E Comasco; I Nylander; K W Nilsson
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.